Method for predicting development of interstitial pneumonia by quantifying MUC-1
Development of interstitial pneumonia due to administration of a drug can be predicted by quantifying MUC-1 in a body fluid; and determining that a possibility for the development of interstitial pneumonia is high when the amount of MUC-1 exhibits a value higher than a normal value.
1 . A method for predicting development of interstitial pneumonia due to administration of a drug, comprising: quantifying MUC-1 in a body fluid; and determining that a possibility for the development of interstitial pneumonia is high when the amount of MUC-1 exhibits a value higher than a normal value.
2 . The method according to claim 1 , wherein the drug is interferon.
3 . The method according to claim 2 , wherein the interferon is interferon α.
4 . The method according to any one of claim 1 , wherein MUC-1 is quantified by an immunochemical method.
5 . The method according to claim 2 , wherein MUC-1 is quantified by an immunochemical method.
6 . The method according to claim 3 , wherein MUC-1 is quantified by an immunochemical method.
7 . The method according to claim 4 , wherein the immunochemical method is an immunochemical method using KL-6 antibody.
8 . A reagent for predicting development of interstitial pneumonia due to administration of a drug, comprising an antibody against MUC-1.
9 . The reagent according to claim 8 , wherein the antibody against MUC-1 is KL-6 antibody.